SAM Holdings warns of a profit slump in FY24

Thanks to a slower-than-expected expansion in business operations.

The Singapore Institute of Advanced Medicine (SAM Holdings) expects a significant net loss for the fiscal year ended 30 June 2024 (FY 2024), due to the group’s slower-than-expected progress in its business operations, which may result in impairment to its assets.

Ahead of its preliminary FY 2024 results, the company said in a local bourse filing “there is a risk that the Group may continue reporting losses.”

The group incurred loss after tax in FY23 due to the continued development and expansion of business operations, with risks of continued reported losses.

SAM Holdings is in the process of finalising its unaudited financial results. Further details will be disclosed on or before 29 August.

Follow the link for more news on

Financial Statements

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia